Clinical trial
Dexamethasone Intravitreal Implant for the Management of Exudative Retinal Detachment in Patients With Uveal Melanoma
NCT04082962 is registered in ClinicalTrials.gov with Ivana K. Kim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone Intravitreal Implant for the Management of Exudative Retinal Detachment in Patients With Uveal Melanoma
- Lead sponsor
- Ivana K. Kim
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 11, 2018
- Completion date
- December 7, 2023
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exudative retinal detachment and uveal melanoma